Almirall announces an international agreement with Basilea to commercialize Toctino® (alitretinoin) for severe chronic hand eczema

Toctino® is the only therapy approved for adults with severe chronic hand eczema (CHE) unresponsive to potent topical corticosteroids

The release as fetched from its publisher. almirall.com ↗